From 1 November 2023, genetic carrier screening for SMA, Cystic Fibrosis and Fragile X syndrome was made freely available through Medicare to Australians who are pregnant or planning a pregnancy and their reproductive partner, helping them to make more informed reproductive choices. For those people who do not meet these Medicare criteria, testing is available at a cost. Speak to your testing provider for further information.